Apheresis Equipment Market Report 2025

The apheresis equipment market size has grown rapidly in recent years. It will grow from $3.84 billion in 2024 to $4.33 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth during the historic period can be attributed to the increasing number of surgical procedures requiring component therapy, rising demand for personalized medicine approaches, expanding applications in oncology and neurology, growing government support for blood disorder treatments, and improvements in the efficiency and precision of apheresis procedures.

The apheresis equipment market size is expected to see rapid growth in the next few years. It will grow to $6.92 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth during the forecast period can be attributed to the rising incidence of rare genetic diseases, increasing demand for targeted blood component therapies, growing frequency of trauma and accident cases, escalating number of elderly patients requiring blood treatments, and an increase in chronic disease-related hospitalizations. Key trends in the forecast period include advancements in portable and compact apheresis devices, development of AI-integrated monitoring systems, innovations in blood component separation technologies, emergence of personalized apheresis protocols, and expansion of home-based apheresis solutions.

The increasing prevalence of blood disorders is expected to drive the growth of the apheresis equipment market in the coming years. Blood disorders are conditions that affect various components of the blood, including red blood cells, white blood cells, platelets, or plasma. The rising incidence of these disorders is largely attributed to the growing prevalence of chronic diseases, which directly impact blood health and require continuous monitoring. Apheresis equipment facilitates effective management of blood disorders by allowing precise separation and removal of specific blood components. These advanced technologies enhance patient care by improving safety, reducing procedure time, and optimizing treatment efficiency. For example, in April 2024, the Perth Blood Institute, an Australia-based non-profit organization, reported that the number of people diagnosed with hemophilia, a genetic disorder in which blood lacks proper clotting factors, leading to prolonged bleeding rose from 233,577 in 2021 to 257,146 in 2022. Consequently, the rising prevalence of blood disorders is fueling the growth of the apheresis equipment market.

Companies in the apheresis equipment market are focusing on developing innovative products, such as advanced venous access techniques, to enhance patient comfort, reduce procedure duration, and improve treatment efficiency. Venous access techniques involve technologies designed to make the insertion of needles or catheters into veins safer, easier, and more efficient. For instance, in April 2023, Fresenius Kabi AG, a Germany-based medical technology company, introduced a single-needle venous access option for its Amicus extracorporeal photopheresis (ECP) system. This solution allows clinicians to seamlessly switch between single-needle and double-needle access during procedures, includes advanced software upgrades, and utilizes a single-use disposable kit for easy setup, further streamlining clinical workflows. It enhances patient comfort, minimizes the risk of complications, and improves the overall efficiency of apheresis treatments.

In November 2024, Macopharma International Group S.A.S., a France-based medical device company, acquired Lmb Technologie GmbH for an undisclosed amount. Through this acquisition, Macopharma seeks to expand its blood processing solutions, strengthen its global presence, and drive growth by integrating Lmb Technologie’s expertise. Lmb Technologie GmbH, based in Germany, specializes in providing apheresis equipment.

Major players in the apheresis equipment market are Asahi Kasei Medical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Terumo Blood and Cell Technologies Inc., Kaneka Corporation, Sumitomo Bakelite Co. Ltd., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma S.A., B. Braun Melsungen AG, Cerus Corporation, Infomed S.A., Medica S.p.A., Baihe Medical Technology Co. Ltd., Brightwake Limited, Kawasumi Laboratories Inc., Haier Biomedical Co. Ltd., Nigale Biomedical Inc., Apheresis Technologies LLC.

North America was the largest region in the apheresis equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in apheresis equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the apheresis equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Apheresis equipment refers to specialized medical devices designed to isolate and extract specific components from blood while returning the remaining components to the donor or patient. These devices are used to separate and remove particular harmful or therapeutic blood elements, such as plasma, white blood cells, platelets, or stem cells, from a donor or patient.

The key types of apheresis equipment include plasmapheresis equipment, photopheresis equipment, low-density lipoprotein (LDL) apheresis equipment, and others. Plasmapheresis equipment is a medical device that isolates and removes plasma from the blood to treat autoimmune and plasma-related disorders, thereby supporting patient recovery. The technologies employed in this equipment include centrifugation and membrane filtration. These devices are applied in areas such as renal diseases, hematology, neurology, and more, with key end-users including hospitals, ambulatory surgical centers (ASCs), blood donation centers, and other healthcare facilities.

The apheresis equipment market research report is one of a series of new reports that provides apheresis equipment market statistics, including apheresis equipment industry global market size, regional shares, competitors with the apheresis equipment market share, apheresis equipment market segments, market trends, and opportunities, and any further data you may need to thrive in the apheresis equipment industry. This apheresis equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The apheresis equipment market consists of revenues earned by entities by providing services such as blood component separation, plasma exchange, photopheresis treatment, therapeutic plasma exchange, and related maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The apheresis equipment market also includes sales of centrifugal apheresis machines, membrane filtration devices, blood cell separators, plasma separators, and platelet separators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.